What’s next for hot biotech stock Viking Therapeutics? Here’s how the company can scale up.
Viking has long been viewed as a takeover target, given the positive data from early VK2735 trials. The company’s most recent update was in early November at Obesity Week, an ev ...
Yahoo Finance29d
Viking Therapeutics Announces Initiation of Phase 2 VENTURE-Oral Dosing Trial of VK2735 Tablet Formulation in Patients with Obesity
13-Week Study to Evaluate the Safety and Efficacy of Oral VK2735 Dosed Once Daily SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage ...